In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., also had been resolved. Zepbound is approved to treat obesity and Mounjaro ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Products featured in this Mail Best article are selected by our ... you determine your coverage on popular weight loss drugs like Ozempic, Wegovy, and Zepbound. If you're new to Ro, they'll ...

It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

Novo Nordisk (NYSE: NVO) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli ...

Companies argue they’re filling a need created by these miracle weight-loss drugs. But are they offering something of real value — or simply taking advantage of another food fad?

“These are life-changing medications.” The FDA has approved Wegovy to reduce heart attack ... to monitor all our patients carefully. The best use of this class of drug would be leveraging ...

Food companies are rushing to reformulate products for protein lovers. That’s a category that includes both people taking the powerful new class of obesity drugs known as GLP-1s, who are ...

The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...